Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AKAO

Achaogen (AKAO) Stock Price, News & Analysis

Achaogen logo

About Achaogen Stock (NASDAQ:AKAO)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.11
$0.11
52-Week Range
N/A
Volume
N/A
Average Volume
3.34 million shs
Market Capitalization
$7.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AKAO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Achaogen and its competitors with MarketBeat's FREE daily newsletter.

AKAO Stock News Headlines

Harry R Weller's Net Worth
Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
Ravi Viswanathan's Net Worth
AKAOQ Historical Data
See More Headlines

AKAO Stock Analysis - Frequently Asked Questions

Achaogen Inc (NASDAQ:AKAO) released its quarterly earnings results on Monday, August, 6th. The biopharmaceutical company reported ($1.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.92) by $0.19. The biopharmaceutical company had revenue of $2.56 million for the quarter, compared to the consensus estimate of $1.49 million. Achaogen had a negative trailing twelve-month return on equity of 357.49% and a negative net margin of 2,136.94%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Achaogen investors own include Intelsat (I), Bank of America (BAC), Fossil Group (FOSL), Associated British Foods (ABF), Chaarat Gold (CGH), AMC Entertainment (AMC) and Ciena (CIEN).

Company Calendar

Last Earnings
8/06/2018
Today
7/13/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:AKAO
CIK
1301501
Fax
N/A
Employees
206
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.70)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$186.51 million
Net Margins
-2,136.94%
Pretax Margin
N/A
Return on Equity
-357.49%
Return on Assets
-127.68%

Debt

Debt-to-Equity Ratio
1.00
Current Ratio
0.78
Quick Ratio
0.77

Sales & Book Value

Annual Sales
$8.73 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.13) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
63,880,000
Free Float
N/A
Market Cap
$7.03 million
Optionable
Optionable
Beta
0.78
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:AKAO) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners